The effect of local anaesthesia on postoperative pain and hemostasis after dental rehabilitation under general anaesthesia in pediatric patients

ISRCTN ISRCTN18557910
DOI https://doi.org/10.1186/ISRCTN18557910
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number Nil known
Sponsor Jordan Ministry of Health
Funder Investigator initiated and funded
Submission date
31/12/2022
Registration date
08/01/2023
Last edited
12/03/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Dental caries, also known as tooth decay, is a common disease that affects children. It has multiple causes and its treatment can be challenging, especially when the child is uncooperative. In such cases, dental treatment under general anaesthesia may be used. However, the use of local anaesthesia as an alternative is a controversial issue. The aim of the study is to investigate the effects of using local anaesthesia on post-operative pain and bleeding after dental treatment under general anaesthesia in children.
This research aims to study the effect of local anaesthesia on postoperative pain and hemostasis after Dental rehabilitation under general anaesthesia.

Who can participate?
Children of both genders aged three to seven years, described by Frankel’s behavior rating scale as definitely negative.

What does the study involve?
The usage or not of local anaesthesia agents when treating children under general anaesthesia.

What are the possible benefits and risks of participating?
One of the benefits is the reduction in both pain and bleeding post-operatively as mentioned in some studies.
The risk of using local anaesthesia when treating children under general anaesthesia is an overdose of the used agent and the interaction with general anaesthesia agents.

Where is the study run from?
Al Bashir hospital (Jordan)

When is the study starting and how long is it expected to run for?


Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Amal Batarseh, amal_batarseh@yahoo.com

Contact information

Dr Amal Batarseh
Scientific

ALhashimi Alshamaly
Basman Erea
Hay Naifah
Next to Prince Hamazah Hospital
P.O.Box: 86
Amman
11118
Jordan

ORCiD logoORCID ID 0000-0002-1218-3858
Phone +962 5200230
Email amal_batarseh@yahoo.com

Study information

Primary study designInterventional
Study designSingle-arm parallel-design single-blinded randomized controlled study
Secondary study designRandomised controlled trial
Participant information sheet 42974 PIS.pdf
Scientific titleThe effect of local anaesthesia on postoperative pain and hemostasis after dental rehabilitation under general anaesthesia in pediatric patients aged from three to seven years old
Study objectivesLocal anaesthesia effects on postoperative pain and hemostasis
Ethics approval(s)Approved 20/02/2020, Scientific Research Ethics Committee (Ministry of Health, ALhashimi Alshamaly, Basman Erea, Hay Naifah, Next to Prince Hamazah Hospital, P.O.Box: 86, Amman, Jordan; +9625200230; no email provided), ref: Moh/REC/2020/44
Health condition(s) or problem(s) studiedPost operative pain following dental treatment under general anaesthesia
InterventionForty-six boys and girls were included in this single-arm, parallel-design, single-blinded, randomized, controlled study. Before the commencement of the study, numbers from one to forty-six were randomly assigned as with local anaesthesia (LA) or without LA in closed envelope.

Group A: given LA which is (2% weight/volume (w/v) lidocaine with 1:80000 epinephrine) by calculating the dose according to the provided formula not exceeding 4.4 mg/kg.
Group B: not given any extra medication
Intervention typeProcedure/Surgery
Primary outcome measure(s)

Pain measured using:
1. Universal-pain-assessment-tool (UPAT) before the operation
2. FLACC behavior scale immediately after treatment, 30 min and 6 hours

Key secondary outcome measure(s)

Hemostasis measured using bleeding score obtained immediately after extraction using the Boezaart-surgical-field-grading-scale.

Completion date01/03/2022

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit3 Years
Upper age limit7 Years
SexAll
Target sample size at registration46
Total final enrolment43
Key inclusion criteria1. Aged three to seven years
2. Described by Frankel’s behavior rating scale as definitely negative.
3. Arabic-speaking and healthy, with an American Society of Anesthesiologists (ASA) I or II classification
Key exclusion criteria1. Needing treatment or extraction of permanent teeth
2. Having an either medical, mental, or physical impairment
3. Need only restorative treatment without extraction or vice versa
Date of first enrolment01/03/2020
Date of final enrolment01/03/2022

Locations

Countries of recruitment

  • Jordan

Study participating centre

Al Bashir hospital
Amman
-
Jordan

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
amal_batarseh@yahoo.com

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 27/11/2023 12/03/2025 Yes No
Other unpublished results 13/02/2023 No No
Other unpublished results Participant flow diagram 13/02/2023 No No
Participant information sheet 04/01/2023 No Yes
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Additional files

42974 PIS.pdf
Participant information sheet
42974 Results Report.pdf
Other unpublished results
42974 Participant flow diagram.pdf
Participant flow diagram

Editorial Notes

12/03/2025: Publication reference added.
NHW 20/02/2023: Internal review.
13/02/2023: A results report and participant flow diagram (unpublished) was added.
04/01/2023: Trial's existence confirmed by Ministry of Health, Jordan.